About BioVeda China Fund
BioVeda China Fund functions as a venture capital entity with a focus on healthcare sectors, including HealthTech, medical devices, diagnostics, and healthcare services. Investments are targeted at companies operating in China and the US. Portfolio holdings encompass firms such as MicuRx Pharmaceuticals, Clarus Therapeutics, Quark Pharmaceuticals, and Cathay Biotech. Assets under management are valued at 400 million, with operations based in Huangpu, China.
- Headquarter Huangpu, China
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioVeda China Fund
Detailed funding history for BioVeda China Fund
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioVeda China Fund
Investment portfolio details for BioVeda China Fund
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioVeda China Fund
Detailed financials for BioVeda China Fund
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioveda China Fund Comparisons
Peer comparison for BioVeda China Fund
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioVeda China Fund
Detailed competitors of BioVeda China Fund
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioveda China Fund
Complete news archive for BioVeda China Fund
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioVeda China Fund
BioVeda China Fund is headquartered in Huangpu, China. It is registered at Huangpu, Shanghai, China.
BioVeda China Fund functions as a venture capital entity with a focus on healthcare sectors, including HealthTech, medical devices, diagnostics, and healthcare services. Investments are targeted at companies operating in China and the US. Portfolio holdings encompass firms such as MicuRx Pharmaceuticals, Clarus Therapeutics, Quark Pharmaceuticals, and Cathay Biotech. Assets under management are valued at 400 million, with operations based in Huangpu, China.